期刊文献+

蛋白酶活化受体2在皮肤生理病理功能中的研究进展 被引量:1

Pathophysiological function of proteinase activated receptor 2 in skin
原文传递
导出
摘要 蛋白酶活化受体2在皮肤的多种细胞均有表达,包括角质形成细胞、成纤维细胞、汗腺、真皮血管内皮细胞和外周神经纤维以及免疫活性细胞,如中性粒细胞、嗜酸粒细胞和肥大细胞。炎症性皮肤病如特应性皮炎、银屑病中PAR-2的表达显著上升,而在白癜风和基底细胞癌中则表达下调。蛋白酶活化受体2可被各种内外源性丝氨酸蛋白酶激活,活化后引起各种细胞因子和趋化因子的分泌和释放,主要发挥前炎症效应,促进炎症的发生,亦可调节皮肤的自我平衡和肿瘤监视。 Proteinase activated receptor 2 (PAR-2) is distributed in various skin cell types including keratinoeytes, fibrohlasts, sweat gland cells,dermal vascular endothelial cells, peripheral nerve fibers and immunologically competent cells such as neutrophils, eosinophils and mast cells, The expression level of PAR- 2 is significantly increased in inflammatory skin diseases such as atopic dermatitis and psoriasis, but reduced in skin lesions of vitiligo and basal cell carcinoma. Many kinds of endogenous and exogenous serine proteases can activate PAR-2, and activated PAR-2 mainly plays a proinflammatory effect and can promote the development of inflammation by inducing the secretion of various cytokines and release of chemokines. PAR-2 also rezulates skin homeostasis and tumor surveillance.
出处 《国际皮肤性病学杂志》 2012年第3期183-186,共4页 International Journal of Dermatology and Venereology
关键词 皮肤 受体 PAR-2 丝氨酸内肽酶类 Skin Receptor, PAR-2 Serine endopeptidases
  • 相关文献

参考文献29

  • 1Steinhoff M, Buddenkotte J, Shpacovitch V, et al. Proteinase- activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev, 2005, 26 (1): 1-43.
  • 2Kato T, Takai T, Fujimura T, et al. Mite serine protease activates protease-aetivated receptor-2 and induces eytokine release in human keratinoeytes. Allergy, 2009, 64 (9): 1366-1374.
  • 3Chiu LL, Perng DW, Yu CH, et al. Mold allergen, pen C 13, induces IL-8 expression in human airway epithelial cells by activating protease-activated receptor 1 and 2. J Immunol, 2007, 178(8): 5237-5244.
  • 4Kelso EB, Lockhart JC, Hembrough T, et al. Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation. J Pharmacol Exp Ther, 2006, 316(3): 1017-1024.
  • 5Kanke T, Kabeya M, Kubo S, et al. Novel antagonists for proteinase-aetivated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo. Br J Pharmacol, 2009, 158(1 ): 361-371.
  • 6Barry GD, Suen JY, Le GT, et al. Novel agonists and antagonists for human protease activated receptor 2. J Med Chem, 2010, 53 (20): 7428-7440.
  • 7Saito A, Osuga Y, Yoshino O, et al. TGF-βI induces proteinase- activated receptor 2 (PAR2) expression in endometriotic stromal ceils and stimulates PAR2 activation-induced secretion of IL-6. Hum Reprod, 2011, 26(7): 1892-1898.
  • 8Materazzi S, Pellerito S, Di Serio C, et al. Analysis of protease- activated receptor-1 and -2 in human scar formation. J Pathol, 2007, 212(4): 440-449.
  • 9Mannowetz N, Wtirdinger R, Zippel A, et al. Expression of proteinase-activated receptor-2 (PAR2) is androgen- dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia. Prostate, 2010, 70(12): 1350-1358.
  • 10Steinhoff M, Corvera CU, Thoma MS, et al. Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol, 1999, 8 (4): 282-294.

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部